Afala tab for the races. 100 pieces

Description

Composition
Active substance:
Antibodies to prostate-antigen affinity-purified – 0,003g *.
* Applied to the lactose as a water-alcohol mixture with a content of no more than 10-15 ng / g of the active form of the active ingredient.
Excipients:
Lactose monohydrate (Lactose) 0.267 g, 0.03 g of microcrystalline cellulose, magnesium stearate 0.003 g
Description:
Tablets ploskotsilindricheskoy shape, with the notch and chamfer, from white to almost white color. On the flat side coated with Valium inscription MATERIA MEDICA, on the other flat side applied AFALA inscription.
Product form:
Lozenges. 20 tablets in blisters of PVC film and aluminum foil.
5 the contour of cellular packaging together with instructions for use placed in a pile of cardboard.
Contraindications
Increased individual sensitivity to the drug. Not recommended for use in patients under the age of 18 years due to insufficient data on efficacy and safety for this age.
Indications
Benign prostate hyperplasia stages I and II.
In the complex treatment of acute and chronic prostatitis – as an anti-inflammatory and analgesic.
Dysuric disorders (frequent urge to urinate, including night, difficulty in urination, pain or discomfort in the crotch region), including the accompanying benign prostatic hyperplasia stages I and II; acute and chronic prostatitis.
Interaction with other drugs
Incompatibilities with other drugs has not yet been registered.
Overdose
Accidental overdosing possible diarrheal phenomena caused by members of the dosage form excipients.
pharmachologic effect
Pharmacological group:
Benign prostatic hyperplasia means of treatment.
Pharmacodynamics:
It reduces inflammation and swelling effects in the prostate gland and normalizes its functional state. Improves urodynamics, it reduces the amount of residual urine, and normalizes the tone of the lower urinary tract, reduces dizuricheskih disorders.
Pharmacokinetics:
Sensitivity modern physico-chemical methods of analysis (gas-liquid chromatography, high performance liquid chromatography, gas chromatography-mass spectrometry) does not allow to evaluate the content of ultra-low doses of antibodies in biological fluids, organs and tissues, making it impossible to study the pharmacokinetics technically Afala preparation.
Pregnancy and breast-feeding
Afala The drug is not intended for use in women.
Conditions of supply of pharmacies
Without recipe
side effects
Possible reactions of individual hypersensitivity to the drug.
special instructions
The preparation includes lactose monohydrate, and therefore it is not recommended for patients with congenital galactosemia, malabsorption of glucose or galactose, or with congenital lactase deficiency.
Effect on vehicle management ability.
Afala does not affect the ability to drive vehicles and other potentially dangerous machinery.
Storage conditions
At temperatures above 25 ° C.
Keep out of the reach of children.
During the period of the drug store contour cell pack in a cardboard bundle provided by the manufacturer.
Dosing and Administration
Inside. At a time 2 tablets (kept in the mouth until complete dissolution – not during a meal). The drug is taken twice a day, morning and evening (before and after sleep). The recommended dosing duration – 16 weeks.
When expressed pain syndrome and dizuricheskih Abuse -3 first 2 weeks of treatment is shown the drug to 4 times per day.
If necessary, a doctor’s recommendation for the re-treatment is possible in 1 – 4 months.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist